Factor VIII: Perspectives on Immunogenicity and Tolerogenic Strategies

14Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

Abstract

Therapeutic treatment of bleeds with FVIII can lead to an antibody response that effectively inhibits its function. Herein, we review the factors that contribute to this immunogenicity and possible ways to overcome it.

Cite

CITATION STYLE

APA

Scott, D. W., & Pratt, K. P. (2020, January 17). Factor VIII: Perspectives on Immunogenicity and Tolerogenic Strategies. Frontiers in Immunology. Frontiers Media S.A. https://doi.org/10.3389/fimmu.2019.03078

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free